InMode (INMD) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.37
- Estimate
- $0.32
- Surprise
- +14.9%
- Score today
- 5.9/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
InMode (INMD) beat the $0.32 estimate with adjusted EPS of $0.37 — a large 14.9% upside surprise.
Coverage in the report window
- Baird Maintains Neutral on InMode, Lowers Price Target to $15 — benzinga, 2026-11-12
- InMode Reports Third Quarter 2026 Financial Results — fiscal.ai, 2026-11-11
- InMode Q3 Adj. EPS $0.37 Beats $0.32 Estimate, Sales $92.138M Beat $91.600M Estimate — benzinga, 2026-11-11
Where TrendMatrix's rating stands now
TrendMatrix currently rates INMD Hold at 5.9/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +14.9% surprise compares with a +3.7% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Analyst target reached - limited upside remaining
- Weak growth
- Below 200-day MA
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $13.73
- Price target
- $13.74
- Stop
- $12.85
- Upside to target
- +0.1%
- Reward-to-risk
- 0.0:1
At 11.3× trailing and 10.0× forward earnings, consensus estimates imply little change in earnings power.
Risk check: trading volume is running 1.6× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-12 — shown for context, not personalized investment advice.
INMD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $790.1M
- P/E (fwd)
- 10.0
- P/E (ttm)
- 11.3
- 52-week range
- $12.72–$16.67
- Off 52-week high
- 17.6%
- RSI (14)
- 46
- Volume vs avg
- 1.62×
- Score today
- 5.9/10